ADCT
Price
$1.16
Change
-$0.03 (-2.54%)
Updated
Apr 7, 04:00 PM (EDT)
Capitalization
116.92M
35 days until earnings call
IBRX
Price
$2.67
Change
-$0.16 (-5.65%)
Updated
Apr 7, 04:43 PM (EDT)
Capitalization
2.42B
31 days until earnings call
Ad is loading...

ADCT vs IBRX

Header iconADCT vs IBRX Comparison
Open Charts ADCT vs IBRXBanner chart's image
ADC Therapeutics SA
Price$1.16
Change-$0.03 (-2.54%)
Volume$1K
Capitalization116.92M
ImmunityBio
Price$2.67
Change-$0.16 (-5.65%)
Volume$7.37K
Capitalization2.42B
ADCT vs IBRX Comparison Chart
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. IBRX commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and IBRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (ADCT: $1.18 vs. IBRX: $2.83)
Brand notoriety: ADCT and IBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 168% vs. IBRX: 131%
Market capitalization -- ADCT: $116.92M vs. IBRX: $2.42B
ADCT [@Biotechnology] is valued at $116.92M. IBRX’s [@Biotechnology] market capitalization is $2.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileIBRX’s FA Score has 1 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • IBRX’s FA Score: 1 green, 4 red.
According to our system of comparison, IBRX is a better buy in the long-term than ADCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 4 TA indicator(s) are bullish while IBRX’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 4 bullish, 5 bearish.
  • IBRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ADCT and IBRX are a bad buy in the short-term.

Price Growth

ADCT (@Biotechnology) experienced а -20.81% price change this week, while IBRX (@Biotechnology) price change was -9.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.10%. For the same industry, the average monthly price growth was -18.64%, and the average quarterly price growth was -18.98%.

Reported Earning Dates

ADCT is expected to report earnings on May 12, 2025.

IBRX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-10.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($2.42B) has a higher market cap than ADCT($117M). IBRX YTD gains are higher at: 10.547 vs. ADCT (-40.704). ADCT has higher annual earnings (EBITDA): -110.43M vs. IBRX (-264.43M). ADCT has more cash in the bank: 274M vs. IBRX (150M). ADCT has less debt than IBRX: ADCT (125M) vs IBRX (504M). ADCT has higher revenues than IBRX: ADCT (70.7M) vs IBRX (14.7M).
ADCTIBRXADCT / IBRX
Capitalization117M2.42B5%
EBITDA-110.43M-264.43M42%
Gain YTD-40.70410.547-386%
P/E RatioN/AN/A-
Revenue70.7M14.7M481%
Total Cash274M150M183%
Total Debt125M504M25%
FUNDAMENTALS RATINGS
IBRX: Fundamental Ratings
IBRX
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTIBRX
RSI
ODDS (%)
Bullish Trend 7 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
82%
Momentum
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
77%
MACD
ODDS (%)
Bearish Trend 7 days ago
87%
Bullish Trend 7 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 26 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
88%
Bearish Trend 7 days ago
88%
Aroon
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.492.39
+11.33%
GameStop Corp
SPY505.28-31.42
-5.85%
SPDR® S&P 500® ETF Trust
BTC.X78214.484000-5290.312500
-6.34%
Bitcoin cryptocurrency
AAPL188.38-14.81
-7.29%
Apple
TSLA239.43-27.85
-10.42%
Tesla

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with CLRB. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
-4.07%
CLRB - ADCT
47%
Loosely correlated
-9.82%
ANAB - ADCT
41%
Loosely correlated
-4.04%
PRME - ADCT
39%
Loosely correlated
-12.42%
AURA - ADCT
39%
Loosely correlated
-4.90%
SPRB - ADCT
38%
Loosely correlated
-4.13%
More

IBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBRX has been loosely correlated with CLRB. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IBRX jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBRX
1D Price
Change %
IBRX100%
-4.71%
CLRB - IBRX
38%
Loosely correlated
-9.82%
ADCT - IBRX
35%
Loosely correlated
-4.07%
ANAB - IBRX
33%
Loosely correlated
-4.04%
EYPT - IBRX
33%
Loosely correlated
-7.62%
CGON - IBRX
33%
Poorly correlated
-8.22%
More